Clinical Development of Oncology Products in Japan – the 2nd Largest Market for Innovation

November 19, 2020

*** Thursday, November 19, 2020 | 4:00 pm-5:00 pm EST ***Japan, the second largest market for branded pharmaceuticals and innovation, is driven in part by Oncology with recent advances in genomic analysis technology. In addition, the Japanese market is driven by ongoing regulatory and government initiatives that reward innovation, shifts in population demographics, and increased disease awareness, and identifiable patient populations, amongst other factors. ***On demand available after final airing until Nov. 19, 2021***

Implementing Risk-based Monitoring in Oncology Trials Sharing case studies and insights on the impact to study quality and patient safety

October 29, 2020

***Live: Thursday November 12, 2020 at 11am EST***Oncology trials of various types and phases present unique challenges for effectively conducting trials, and firms are implementing risk-based monitoring (RBM) practices to improve quality and patient safety.***On demand available after final airing until Nov. 12, 2021***

Use of RWE in Clinical Development to Enhance Regulatory Submission

April 07, 2020

Learn more about global regulatory acceptance of real-world evidence in a regulatory submission. Understand how to identify opportunities to incorporate real-world Evidence in your submission package. Live: Tuesday, Apr. 7, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Apr. 7, 2021. Register free

Benchmark Your Clinical Development Plans and Drive Better Clinical Strategy

January 30, 2020

Enter a new era of clinical development planning. Use the power of “big data” and machine learning to generate more accurate plans that embrace uncertainty. Learn how to improve your development planning strategy while reducing trial costs and durations. Live: Thursday, Jan. 30, 2020 at 11am EST | 10am PST | 4pm GMT | 5pm CET On demand available after airing until Jan. 30, 2021. Register free